(Q31122077)

29 June 2017

1 reference

title

The spectrum of neuromyelitis optica (English)

1 reference

29 June 2017

1 reference

5

Brian G Weinshenker

1 reference

29 June 2017

Dean M Wingerchuk

1

1 reference

29 June 2017

Vanda A Lennon

series ordinal

2

1 reference

29 June 2017

Claudia F Lucchinetti

series ordinal

3

1 reference

29 June 2017

Sean J Pittock

series ordinal

4

1 reference

29 June 2017

publication date

1 September 2007

1 reference

29 June 2017

1 reference

29 June 2017

volume

6

1 reference

29 June 2017

issue

9

1 reference

29 June 2017

page(s)

805-815

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

29 June 2017

1 reference

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Multiple sclerosis--the plaque and its pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Natural history of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

1 reference

7 January 2021

Neuromyelitis optica: what it is and what it might be

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The molecular basis of water transport in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic's disease and autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica: clinical predictors of a relapsing course and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Mechanical ventilation and tracheostomy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Respiratory involvement in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic disease with brainstem lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Brain abnormalities in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Optic neuromyelitis syndrome in Brazilian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

CSF electrophoresis in one thousand patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic's neuromyelitis optica: a clinicopathological study of 8 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica in childhood: case report with sequential MRI findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The pattern of neurological illness in tropical Africa. Experience at Ibadan, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Demyelinating disorder of the central nervous system occurring in black South Africans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Optic neuritis in African Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

MS and neuromyelitis optica in Martinique (French West Indies)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Recurrent optic neuromyelitis with endocrinopathies: a new syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Multiple sclerosis in the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Decrease in multiple sclerosis with acute transverse myelitis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Multiple sclerosis in North-West India.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica (Devic's syndrome) in two sisters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

A secondary progressive clinical course is uncommon in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica with unusual vascular changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

An autopsied case of neuromyelitis optica with a large cavitary cerebral lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

NMO-IgG in the diagnosis of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Aquaporin water channels: molecular mechanisms for human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica with hypothalamic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Immunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Expression of complement in the brain: role in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Hyperprolactinemia in optico-spinal multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Magnetization transfer and diffusion tensor MRI show gray matter damage in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Progressive necrotic myelopathy: clinical course in 9 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Chronic relapsing inflammatory optic neuropathy (CRION).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The natural history of recurrent optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Recurrent longitudinal myelitis as primary manifestation of SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Acute transverse myelitis in SLE

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The association of optic neuropathy with transverse myelitis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Steroid-responsive Devic's variant in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Pure optic-spinal form of multiple sclerosis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

OSMS is NMO, but not MS: proven clinically and pathologically

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Plasma exchange for severe optic neuritis: treatment of 10 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

1 reference

7 January 2021

Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

An open label study of the effects of rituximab in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

The lumping and splitting of inflammatory CNS diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2807%2970216-8

7 January 2021

10.1016/S1474-4422(07)70216-8

Identifiers

DOI

1 reference

29 June 2017

1 reference